Schreiber SL, SMITH JK. Absence of the vagina, uterus, right kidney and ureter and ectopic (pelvic) left kidney. Am J Surg. 1946;71:681-8.
Cantley LC, Dalton WS, DuBois RN, et al. AACR Cancer Progress Report 2012. Clin Cancer Res. 2012;18(21 Suppl):S1-100. doi:10.1158/1078-0432.CCR-12-2891
Sternson SM, Louca JB, Wong JC, Schreiber SL. Split--pool synthesis of 1,3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays. J Am Chem Soc. 2001;123(8):1740-7.
Liberles SD, Schreiber SL. Apoptosis-inducing natural products found in utero during murine pregnancy. Chem Biol. 2000;7(5):365-72.
Martins MM, Zhou AY, Corella A, et al. Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. Cancer Discov. 2015;5(2):154-67. doi:10.1158/2159-8290.CD-14-0552
Schreiber SL. [2 + 2] photocycloadditions in the synthesis of chiral molecules. Science. 1985;227(4689):857-63.
Cimprich KA, Shin TB, Keith CT, Schreiber SL. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc Natl Acad Sci U S A. 1996;93(7):2850-5.
Yu H, Rosen MK, Saccomano NA, Phillips D, Volkmann RA, Schreiber SL. Sequential assignment and structure determination of spider toxin omega-Aga-IVB. Biochemistry. 1993;32(48):13123-9.
Bargiela D, Bianchi MT, Westover B, et al. Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis. Neurology. 2017;88(7):677-684. doi:10.1212/WNL.0000000000003612
Wilson AJ, Holson E, Wagner F, et al. The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells. Cancer Biol Ther. 2011;12(6):484-93. doi:10.4161/cbt.12.6.15956